Adulsa Therapeutics Corp — Form D

Adulsa Therapeutics Corp of BERWYN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-13. The offering totals $3.5M, of which $525K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-10-13
• Form: D
• Accession: 0001887934-21-000001
• Industry: Biotechnology
• Exemptions: 04
• Total offering: $3.5M
• Amount sold: $525K
• Remaining: $3.0M
• Investors: 2
• Date of first sale: 2021-07-08
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-416818

Issuer

• Name: Adulsa Therapeutics Corp
• CIK: 0001887934
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 1055 WESTLAKES DR, BERWYN, PA, 19312
• Phone: 4844324250

Officers, directors & promoters (1)

More

• CIK 1887934 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search